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After seeing the end stage of several cases of the 
disease trachoma I was stimulated to investigate, through 
the medium of reading, the cause and treatment of the dis-
ease. Because it is the leading cause of blindness in var-
ious sections of the world and because the majority of 
students may practice medicine in those parts of the coun-
try where trachorna is prevalent I feel that any time spent 
on the subject is of great value. 
I have limited this paper to the etiology of trachoma. 
and its treatment with sulfanilamide chiefly because the 
literature on all phases of the disease is so voluminous 
that to cover it would take more time than ie allotted, 
and because I feel that the causative agent and treatment 
go hand in hand, therefore, cannot be divorced. 
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HISTORICAL BACKGROUND OF THE OCCURRENCE OF TRACHON....A 
In the ancient Egyptian manuscript, the Papyrus 
Ebers (5), which dates back to the eighteenth dynasty 
or to a period of time estimated to be 1553 - 1500 B.c., 
is found the expression 'hetae m mrt'. This has been in-
terpreted as referring to trachoma. So it is seen that 
trachoma is one of the oldest diseases known. Even though 
there is considerable literature on Egypt little or no 
mention of trachoma. is found so it is reasonable to assume 
that the disease was not as prevalent or as severe as it 
is today or was in the comparatively recent past. In 1481 
Rabbi Meshoolam Ibn Menahen referred to trachoma; a cen-
tury later Prosper Alpinus, a Venetian physician, again 
ref erred to the disease and from this time on trachoma. be-
came permanently and commonly implanted in Egypt (24). 
It is a well known fact that eye diseases have always 
been common in the Orient and trachoma. undoubtedly was pre-
sent in the ancient Orient. Mijaachita states that in Japan 
trachoma. dates back as far as 1200 years ago (46). 
Herodatus (482 - 424 B.C.) is thought to have been 
the first of the Greeks to ref er to trachoma., the evidence 
consisting of his comment concerning the discharge of two 
of thirty-two soldiers at Thermopylae because of ophthalmia, 
the expression signifying trachoma. Aristophanes (444 - 380 
B.C.) discussed in a summary fashion the cure and treatment 
of the disease in Plutue and again refers to the afflic-
tion in Frogs. Hippocrates (460 - 3?? B.C.) wrote a des-
scription of ophthalmia and trichiasis, and for treatment 
recommended applications of copper acetate and fresh gra.pe 
juice. Also Plato, Aristotle, and Plutarch were aware of 
the disease (24). 
The Aramaics or Syriacs knew of trachoma and pannus 
because they designated trachoma as 'garab' and pannus as 
'sebel' and recommened scraping and scarification in the 
treatment. The book on ophthamology " Tadkirat-el-Kahhalint• 
written at Bagdad in the eleventh century by Ali Ibn-el-
Aissa is probably the oldest book on diseases of the eye 
that has been preserved in it's original language. In this 
book is found an entire chapter on trachoma and the treat-
ment is quite detailed for each of the four stages of the 
disease. So this may be judiciously accepted as evidence 
of the importance attributed to trachoma by the Arabic 
physicians (9). 
From the material presented so far it is seen that 
trachoma was well-known in the old countriee, however, it 
was not until the nineteenth century that Europe became 
fully aware of the disease. At this time under the name of 
Egyptian ophthalmia it was disseminated at a terrific rate 
of speed. 
During 1?98 Napoleon and his armies were invading the 
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land of Egypt and it is thought that this expedition was 
responsible for the spread of trachoma. throughout Europe. 
Larrey, Vetch, and Eble, military surgeons of the French, 
British, and Prussian armies accurately described the dis-
ease and the disability it caused. On the return journey 
the soldiers spread the disease en route and carried it in-
to their native lands. The Russian army did not incur the 
disease during the Napoleonic wars but it was not long after-
wards that it began to appear sporadically in Russia. Con-
sequently trachoma has become firmly implanted in Europe (43). 
When the history of trachoma. in the New World is con-
sidered nothing definite or tangible can be found. Some 
authorities believe that it was imported by the Spanish 
conquistadores (75). But other observers maintain that the 
Spanish probably contracted the disease from the Indians 
and contend that it is of more recent origin (15). Lewis 
and Clark comment a little on "sore eyes" among the Chop-
punieh but it is uncertain as to whether or not they were 
describing trachoma. At the Flathead agency in Montana in 
1868 McCormick reported "sore eyes" and Fox believes that 
the Blackfeet Indians contracted trachoma from the Indians 
at the Flathead agency. On inquiry to the Bureau of Indian 
Affairs Fox learned that the Indians thought that trachoma 
was introduced to them by employees of the Hudson's Bay 
Company. However, he presents sufficient evidence to relieve 
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this blame and states that the Celtic race was entirely 
responsible. By 1910 Hodge and Hrdlicka believed that the 
disease was permanently established among the Indians (15). 
In view of the facts presented above it appears as 
though trachoma in the Indians was of fairly recent origin 
and probably was brought to them by the white man. However, 
Gifford (24) makes a statement that the disease existed 
among the Oma.whawe in 1819 prior to the arrival of white 
men. According to J.J. Wall (74) the Canadian Indians be-
lieve that trachoma was brought to them from .American tribes 
accompanying the early white traders. 
Up to 1850 the immigrants coming to this country were 
mainly British, Irish, German, and Scandinavian and the 
incidence of trachoma. was not so great. But after 1850 the 
immigrants consisted of Italians, Austrians, Slave, Russians 
and Turks for the most part and the incidence of the dis-
ease increased tremendously. Cases and outbreaks of the 
disease, especially among school children and the alien 
population, were noted by numerous observers, and because 
of the contagiousness of the disease and the seriousness 
of it's sequelae it was regarded as a menace to the public 
health. Consequently in 1897 the Treasury Department, then 
in charge of immigration, classified trachoma. as "dangerous 
contagion" and so prevented trachoma.tous individuals from 
entering this country (42,6). 
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In Canada the disease is found also among immigrants 
from Eastern and Southeastern Europe, as well as among the 
Chinese in British Columbia. An endemic focus exists among 
the Daukhobors and the incidence of trachorna. in Manitoba 
and Saskatchewan is still a serious problem (74). 
In Australia the disease appeared with colonization, 
however, it has never been a serious problem and has been 
eliminated except for foci in Northwest Queensland, West 
New South Wales, and the northern and eastern parts of the 
continent (40). 
I was unable to find any statistics on the occurrence 
of trachorna. in Nebraska. However, as a result of direct com-
munication with several ophthamologists who have worked in 
the University of Nebraska Dispensary and outstate men I 
learned that although most of them have seen and treated 
the disease the incidence has not been high in their ex-
periences. 
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THE ETIOLOGY OF TRACHOMA 
Since the time trachoma was first described a number 
of concepts have been advanced to account for the origin 
of the disease. Although most authorities of the present 
generation agree that trachoma. is a specific infectious 
disease there are still some adherents to the numerous and 
varied theories. In the material to follow an attempt to 
review these theories will be made. Also the recent experi-
mental work will be reviewed to try and make it possible 
to present the present day concept of the origin and the 
evolution of the disease. 
Various Theories as to the Causative Agent 
Some observers have advanced the idea that the lymph-
atic constitution of an individual may be an important 
factor, either predisposing or causative. There are not 
many in this country adhering to this idea, in fact, it 
is disputed by some whosay that constituents of this theory 
are describing folliculosis and not trachoma (24). 
Because trachoma. has a high incidence in the lower in-
come group of people, where malnutrition is seen, many aut-
horities (16,58,63) believed that the state of nutrition 
played an important part in the development of the disease. 
But the occurrence in well-nourished persons such as wrest-
lers (49) certainly isn't in keeping with this idea. 
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Even though this concept was advanced before the specific 
knowledge of vitamins came into being (knowing that Vit. 
A plays an important part in the development of eye dis-
eases), recent experiments have failed to show that either 
a defective diet or depressed physical condition is essen-
tial for the development of trachoma (311 73,22,55). In fact 
it seems as though the anima.ls used in the vitamin defic-
iency experiments were less reactive and probably a little 
more resistant to trachoma than normal animals, that is, 
those on an adequate diet. 
From time to time numerous observers have attempted 
to show that trachoma is a manifestation of various clin-
ical entities, such as tuberculosis and syphilis. Accord-
ing to Pascheff (48) tuberculosis is the underlying and 
responsible factor in trachoma.. He believes that the eye 
symptoms arise from an endogenous tuberculous source. This 
is not such an unreasonable concept since it is a well es-
tablished fact that both trachoma and tuberculosis have a 
high incidence among the poverty-stricken and unsanitary 
groups of people. The only support for this idea is the 
differential leucocyte estimation and tuberculin skin tests 
which run parallel in both diseases. However, experimental 
evidence has failed to show any correlation between trachoma. 
and tuberculosis (24). 
Syphilis is another specific disease that has been 
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blamed for the initiation and development of trachoma. 
And some observers contend that symptoms of the disease 
are done away with under antiluetic treatment. But there 
is very little evidence to indicate more than a coincid-
ental relationship, in fact, in the Trachoma. Hospital at 
Rolla, Missouri it is found that trachoma. very rarely 
occurs in syphilitic patients (24). 
Some observers believe that trachoma. is actually a 
local manifestation of a generalized disease and not a 
local disease per se. In these instances the disease is 
thought to be the result of malaria (30), an allergic 
phenomenon (35), a plasmoma., endocrine disturbance, a 
nasal infection, and capillary changes (24). 
From time to time various men (11,12,44) have stated 
that they believe trachoma. is transmitted by different in-
sects. Also, Dr. Myles Standish (62) after observing immi-
grants for a number of years surmised that the acute cases 
must have contracted the disease while on board ship and 
so he advanced the theory of an intermediate insect host 
and named the bed-bug as the insect responsible. Standish 
also assumed that the cases of trachoma seen in loggers, 
who srent the winter in unsanitary camps, and in the Ken-
tucky mountaineers was propogated through the bed-bug. And 
Dr. H.B. Young (77) in a direct rebuttal to Dr. J.M. Patton's 
report on the occurrence of trachoma. in professional wrestlers 
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states that he believes an investigation of the wrestler's 
sleeping quarters for the bed-bug would probably reveal 
it's presence. However, I believe that Dr. Patton (49) has 
rightly assumed that the transmission of trachoma. in his 
series of eight cases in wrestlers was through direct con-
tact rather than through the medium of a bed-bug. Nicolle 
and Cuenod succeeded successfully in transmitting trachoma 
to monkeys with flies and lice but it is not unreasonable 
to assume that objects other than insects can absorb infect-
ious material and so transmit the disease. Thia assumption 
is borne out by the fact that the usual method of spread 
is by coming into contact with infectious material on a 
towel or some other inanimate material used by a trachomatous 
individual. Nicolle and Cuenod allowed their insects to 
absorb infectious material then dissected their heads and 
feet and then inoculated animals. But because their experi-
ments were extremely artificial not much weight is given 
to their results (24). 
Infectious Nature and Transmissibility of Agent 
There is little doubt in the minds of the majority of 
observers that trachoma is a cormnunicable disease. Numerous 
experiments have been undertaken in which man was inoculated 
with trachomatous tissue. Suffice to say that all experiments 
from 1816 to 1937 prove that trachoma is transmissible to man, 
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reproduces itself experimentally as characteristically 
as when it occurs spontaneously, the duration of incu-
bation following inoculation varies considerably from a 
few days to almost a month, and that epithelial cell in-
clusions occur and can be found when they are looked for. 
However, some have stated that the experimental inoculation 
of man with trachoma.tous material resulting in a clinic-
ally typical disease is not due to infection but a com-
bination of trauma and secondary infection. But there is 
sufficient evidence of accidental transmission to man, as 
in doctors and nurses, to rule out such concepts (24). 
While on this subject one might wonder why the incidence 
of trachoma among the ophthamologists and attendants is 
not any greater than it is. The obvious conclusion is 
that trachoma. although infectious is not so highly con-
tagious. 
Experiments (26,27) carried on in the United States 
Trachoma. Hospital at Rolla, Missouri have shown that mon-
keys and apes may be infected with material derived from 
patients with trachoma, that human material is not infec-
tious for other animals and is tolerated without visible 
effect even by monkeys when introduced into tissues other 
than the conjunctiva. The observers (27) also found that 
it was not possible to adapt the infection permanently to 
monkeys, thus indicating a high degree of tissue special-
ization by the infectious agent. They also found that 
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recovery from the experimental disease affords no measur-
able protection to subsequent inoculation with infectious 
tissues. 
Microorganisms Associated with Trachoma. - not Rickettsial 
From the material presented so far it seems as though 
trachoma. is an infectious disease experimentally transmiss-
ible to man, apes, and monkeys. So we find that as far back 
as 1881, when the science of bacteriology first came into 
being, a search for the specific microorganism was initia-
ted. Since that time different biological agents have been 
pointed out as being directly related to trachoma.. Eight 
different observers reported the presence of protozoan 
forms in trachoma.tous tissues but in only one instance was 
transmission attempted and the results indicated that the 
organism was without effect. Six different investigators 
reported that Blastomyces were seen in sections of trachoma-
tous tissue but only one man succeeded in cultivating the 
the organism. Both Cryptococcus and Streptothrix have been 
cultivated from trachoma.tous tissue but the evidence that 
they are etiologically responsible for trachoma. is sadly 
lacking. When it was proven that bacteria cause disease 
then many observers sought to demonstrate a bacterial agent 
as the exciting cause of trachoma. In 1881 Sattler announ-
ced he had found a Gram-positive coccus in both conjunctival 
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discharge and follicular material of trachornatous patients. 
In 1886 Michel found a diplococcus in the discharge and 
follicles of sixty-nine patients but it is very doubtful 
that he was dealing with trachoma. In 188? on four differ-
ent occassions cocci were reported as causative agents. In 
1889 a motile coccus was isolated from trachoma patients. 
Numerous observers since have cultivated cocci from tracho-
matous patients. So it is quite obvious that cocci have 
been isolated on several occassions but the resultant ex-
perimental disease indicates that the conjunctival reaction 
was in general mild and corneal involvement was lacking 
and so cannot be designated as trachoma.. Probably the most 
important observation of this group of investigations was 
that by Noguchi. He demonstrated a rod-shaped organism 
which he called Bacterium granulosis but neither he nor 
several other observers were able to produce orhtodox 
trachoma with this organism. On several occassions different 
investigators have observed a complete lack of specificity 
in the bacteria cultivable from trachoma (24). 
The Rickettsial Nature of Trachoma. 
With the generalized vagueness and doubt of the vari-
ous organisms advanced investigations were directed toward 
some other kind of infectious agent. So in 1933 Busacca 
published the first account in regard to a rickettsial 
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organism. In 1934 he published two more papers on the 
same subject stating that in scrapings derived from the 
cornea during trachoma and stained with Giemsa, could be 
seen small red-staining bodies in masses and isolated 
pairs and that nondescript granules appeared blue. These 
bodies were found between, on, or in epithelial cells, as 
well as in follicles and in pannus and he considered these 
Rickettsiae because they were never observed in normal 
individuals, folliculosis, chronic catarrhal keratocon-
junctivi tis and several other non-ocular conditions. In 
view of these facts Busacca felt that they were specific 
for trachoma and so again in 1937 he reaffirms his belief 
in the rickettsial origin of the disease. 
In 1935 Cuenod observed in Giemsa-stained preparations 
of follicular contents small particles stained pale blue 
or violet and aggregated in irregular masses between the 
epitheloid and mononuclear cells. He designated them as 
"plastilles" but did not classify them. Then in two pub-
lications in 1936, one by himself and the other in conjunc-
tion with Nataf, he says that the plastilles were actually 
rickettsia. Also they described several experiments to 
show that the rickettsial structures cause trachoma and 
multiply in the human body louse. In 1937 these men re-
peated their original observation and in addition produced 
infection in monkeys and a human after purifying the agent 
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by inoculation of guiena pigs intratesticularly. In 1936 
Poleff found riekettsia-like corpuscles which he identi-
fied as those reported previously by Busacca and Cuenod. 
He also reported the successful propogation of the rickett-
sia-like bodies in tissue cultures and suggested the poss-
ibility that these bodies enter into the structure of the 
epithelial cell inclusion. I..e,ter in 1936 Poleff describes 
the technique of cultivation and considered the rickettsial 
forms as a phase of the inclusion bodies (24,1). 
As stated previously, Cuenod and Nataf in 1936 and 
1937 advanced the hypothesis that the louse may be the 
insect vector of trachoma.. They also suggest that the 
theory of the rickettsial nature of trachoma was strength-
ened by the observation that maps showing the geographical 
distribution of the disease were superimposable on those 
of typhus, a definite rickettsial disease. They also suggest 
that the agent is identical with R. rocha lima.e or at least 
closely related (1). However, Weigl challenges this hypo-
thesis on the basis that intra-anal inoculation of tracho-
matous material into normal lice gave negative results and 
R. rocha lirnae did not infect lice (1). In 1937 Foley and 
Parrot (13) confirmed the presence of rickettsial corpuscles 
in trachoma. and identified them with inclusion elementary 
bodies. They also considered trachoma as a local infection 
with rickettsia. Also in 1937 Derkac suggested the theor-
itcal possibility of a positive Weil-Felix test in trachoma. 
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and tested twenty patient's serum of which only five gave 
a positive test and he did not consider his results con-
clusive (1). In a publication by Postic (53) in 1938 he 
considers that there may be a relationship between the 
organisms of trachoma and those of typhus fever. He suggests 
that there may be several groups of trachoma. rickettsiae 
and that each endemic area has a different variety, each 
giving a different agglutination titer. He states that he 
found a certain histological analogy between typhus exan-
thematious and trachoma in the formation of small follicular 
masses around the blood vessels. He also believes that not 
counting possible interference with the result by former 
spotted fever, the Weil-Felix reaction is indisputably of 
importance in demonstrating the role played in trachoma by 
rickettsiae. Poleff (51,52) in two different papers in 1939 
was convinced from his experiments with pure cultures of 
rickettsias that they are identical with the formations 
described by Cuenod and Nataf and were the cause of trachoma. 
He is also of the opinion that the rickettsia-like cor-
puscles described by Busacca and Cuenod, at any rate those 
which are not debri, cellular or otherwise, are identical 
with the inclusion bodies of Halberstadter and Prowazek at 
certain stages of their evolution. 
So far, for the most part, the evidence has been in 
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favor of the rickettsial theory of trachoma. But in 1938, 
Thygeson (68), a most outstanding authority on the problem, 
examined trachomatous material from Tunis, Brazil, and the 
United States for the rickettsia-like bodies described by 
Busacca, Cuenod and Nataf. He found that no minute parasitic 
bodies other than the elementary and initial bodies of the 
epithelial cell inclusion of trachoma could be demonstrated. 
So Thygeson contends that the formations which these obser-
vers described as occurring in large numbers in the trachoma 
follicles are not parasitic but in all probability cell 
granules and cytoplasmic aebri. Grttter, in a 1938 publication 
considers the rickettsiae of trachoma to be inflamatory 
proliferations and divisions of granules which occur nor-
mally in epithelial cells (24). In May, 1939 Braley (3) 
published a report and reached the conclusion that the 
bodies described and photographed by Busacca, Cuenod and 
Nataf, and others undoubtedly represent stained mitochondria 
and keratin granules rather than rickettsia. In October, 
1939 de R8tth (57) was unsuccessful in repeating the exper-
iments of Cuenod and Nataf and states that the appearance 
of the follicles does not prove the transmission of trachoma. 
and so reaches the same conclusions as did Thygeson. In 
July, 1940 Bengtson (1) proposed that the question of the 
rickettsial nature of trachoma was a question of "what are 
rickettsiae?" She concludes that if the criteria is small, 
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bacillary bodies requiring Giemsa stain for demonstration, 
intracellular habitat, an arthropod host, and failure to 
grow on artificial media, it is questionable whether the 
organism of trachoma. could be classified as rickettsial. 
She suggests that perhaps the definition of rickettsiae 
should be broadened to exclude the arthropod host. However, 
she believes that the louse might be an accessory factor. 
S.R. Gifford (l?) in a review of the recent advances in 
ophthamology contends that Busacca, Cuenod and Nataf have 
inconclusive evidence for the rickettsial origin of trachoma. 
From the material presented above one can rightly 
assume that there has been considerable work done in an 
attempt to prove and disprove the rickettsial theory of 
etiology. In my opinion the balance of evidence is against 
the rickettsial theory. However, the opinions of Cuenod, 
Nataf and others have raised a number of questions which 
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are of certain p~tical importance, such as the theory of 
louse transmission and the Weil-Felix reaction as a diagnosis 
of trachoma and cannot be entirely disregarded. Perhaps in 
the near future these questions will be answered. 
The Inclusion Body 
The research done in this field dates back to 190? 
when Halberstadter and Prowazek started investigating tra-
choma while they were on an expedition to Java to study 
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syphilis. Afte inoculating baboons with secretions from 
trachomatous patients they examined Giemsa-stained prep-
arations of scrapings from their conjunctiva and discov-
ered within the epithelial cells collections of granules 
that have since been known as inclusion bodies, epithelial 
cell inclusions, trachoma bodies, Halberstadter and Pro-
wazek bodies, and Prowazek bodies. Because they saw similar 
structures in preparations of material taken from tracho-
matoue patients they concluded this inclusion body was 
the infectious agent of trachoma.. Even at this early date 
these two men put the infectious agent in the same class 
as smallpox, rabies, and molluscum contagiosum, diseases 
that are now considered as virus diseases. They also stated 
that the conjunctival epithelium is the portal of entry 
and chief source of dissemination of the incitant. At the 
same time Halberstadter and Prowazek's work was published 
Greeff described granules which he considered as the inci-
tant of trachoma.. His descriptions of them coincide per-
fectly with the elementary granules of the inclusion body. 
Later, however, he said that they played no part in the 
causation of trachoma. In 1908 Stargardt published a report 
on the inclusion bodies but he felt that other agents were 
able to stimulate epithelial cell inclusions and a year 
later Schmeichler confirmed this idea. Heymann observed 
inclusion bodies in ten of fourteen cases of gonorrheal 
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blenorrhea thereby seriously conflicting with the con-
clusions of Halberstadter and Prowazek (24). So whether 
the inclusion body was a reaction product of the epithelial 
cell in response to gonococcal infection or to the incitant 
of trachoma became a serious problem. 
In 1910 Herzog considered trachoma the result of gono-
coccal infection occurring under special conditions. Then 
Halberstadter and Prowazek tried to answer the perplexing 
problem so they looked for inclusion bodies in genito-
urinary infections in men and women and were unsuccessful. 
And in three infants with gonococcus-free blenorrhea they 
saw many inclusions so they concluded that these inclusion 
bodies were independent of gonococcal infection. However, 
Jancke found inclusion bodies in urethral preparations of 
fifteen of sixteen patients with gonococcal infection. Then 
Lindner showed that the inclusion bodies were found in all 
cases of blenorrhea free of gonococcus so he said that there 
are two blenorrheal diseases, inclusion blenorrhea and gono-
coccal blenorrhea. He stated that the inclusion of blenorrhea 
was indistinguishable from that of trachoma.. Halberstadter 
and Prowazek actually demonstrated cell inclusions in the 
genital epithelium of a mother giving birth to an infant 
with inclusion blenorrhea. They felt the inclusion was 
similar to but not identical with that of trachoma. and des-
ignated it as Chlamydozoon blenorrheae. Later Lindner found 
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inclusions and free initial bodies in three instances of 
non-gonorrheal urethritis of man so he advanced the idea 
that trachoma and inclusion blenorrhea are manifestations 
of the same agent and in 1935 he classified them as trachoma 
and paratrachoma. Heymann considered the inclusion body 
as an unknown independent coexistent virus capable of multi-
plication and transmission to monkeys and apes. Lindner 
and Wolfrum felt that genuine trachoma followed inoculation 
of material from inclusion blenorrhea in man. But Gebb and 
Lehlein did not think it was trachoma. (24). In 1934 Thygeson 
(65) demonstrated inclusion blenorrhea in aduljs was not 
trachoma but swimming-bath conjunctivitis. sit£e then this 
work has been confirmed by Julianelle (24). 
So the work done in this field indicates that in epi-
thelial cells during trachoma there occurs a formation des-
ignated as inclusion body which certain authors regard as 
the infectious agent. Also inclusion bodies may be found 
in other follicular diseases such as inclusion blenorrhea 
and swimming-bath conjunctivitis. The occurrence of the in-
clusion body in experimentally infected humans has been 
accepted by Leber, Prowazek, and Thygeson (6?) as proof of 
its viability. Still others (45,50) say that the inclusion 
body has no relation to trachoma.. Szily, Stanculeanu and 
Mihail, Solovief, and the Duke-Elders (10) believe that 
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the inclusion body is the result of cytological degener-
ation. Herzog, Williams, and Bengtson (2) advanced the 
idea that the inclusion body was phagocytosed material. 
In conclusion, it must be admitted that whatever its 
ultimate nature may be the inclusion body constitutes an 
integral part of trachoma, and, from the microscopical 
point of view it is still the only tangible evidence charac-
teristic of the entire disease. In a later section the re-
lation of the inclusion body, rickettsia, and virus will 
be discussed. 
The Virus Theory 
As far back as 1905, antedating the discovery of the 
inclusion body by two years, Pfeiffer and Kuhnt reported 
on the infectivity of filtrates of human trachomatous mat-
erial obtained by filtration through Berkefeld candles. 
They found the filtrates were not infectious and so con-
cluded that the infectious agent was not filterable and so 
the viral concept indirectly came into being. In 1906 
Baiardi, using Berkefeld filters, carried on similar experi-
ments and reached the same conclusion. Hess and R~mer using 
Berkefeld filters, also came to the same conclusion. In 
1907, Fermis and Repetto in a series of four trials in fil-
tration, only one of wl-ich used proper controls, also came 
to the same conclusion. In 1908, Bertarelli and Cecchetto 
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produced what they considered typical symptoms of experi-
mental trachoma by filtrates. Nicolle, Cuenod and Blaizot 
in 1911 and 1912 reported that the agent of trachoma was 
a filterable virus. Then because everyone was concerned 
with the inclusion body and the advent of the first World 
War filtration experiments were forgotten until 1930. At 
ihis time Trapesontzewa concluded that the infectious agent 
of trachoma was not filterable (24). In 1931 Olitsky, Knutti, 
and Tyler (47) in a series of six filtration experiments 
had one successful inoculation thereby suggesting that the 
process of filtration may be irregular. In 1932 Cattaneo 
after carrying out four experiments on filtration concluded 
that lack of infectivity of filtrates may have been due to 
a loss of virulence during filtration rather than to an in-
ability of the agent to permeate filters. In 1933 Lumbroso 
and Thygeson in a series of six experiments did not get any 
positive inoculations with their filtrates. In 1933 and 1935 
Julianelle and Harrison in a series of eleven experiments on 
filtration obtained only one positive result (26,28). 
In 1935 Thygeson and Proctor (?O) conducted experiments 
in which four inoculations of baboons with bacteria-free 
filtrates of trachoma.tous materials resulted in a disease 
identical with that produced with unfiltered material and 
concluded that these results support the conclusions of 
Nicolle, Cuenod and Blaizot that trachoma. is a filterable virus, 
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Also in 1935 Julianelle and Harrison (28) in a series of 
twelve experiments concluded that filtration of the in-
fectious agent is extremely irregular and that such irreg-
ularities may be due to variations in the tissues as well 
as to the variations in the composition of the filters. 
Again in September, 1935 Thygeson, Proctor, and Richards 
(71) using a colloidion membrane, and thereby eliminating 
absorption of the agent as occurred in the filtration ex-
periments using Berkefeld filters, confirmed the virus 
nature of the etiologic agent of trachoma. In the same 
month and year Thygeson (66) states that the evidence ob-
tained from three different methods of attack on the prob-
lem of the etiology of trachoma. indicates that trachoma. is 
definitely a virus disease. The three methods of attack that 
he mentions are:-
1- Evidence obtained through a process of elimination---
Julianelle and Harrison, Stewart, and Thygeson carried 
out extensive experiments using pure cultures or cultures 
of bacteria pooled in the proportions found on the tracho-
matous conjunctiva without results. 
2- Evidence obtained by filtration experiments 
As previously mentioned above conclusive experiments have 
shown that the agent is filterable under certain conditions. 
3- Evidence obtained by inoculation with bacteria-free tra-
chomatous material ----
Julianelle and Harrison using the method of testicular 
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inoculation which Noguchi developed to rid vaccine 
virus of contaminating bacteria were able to obtain 
active bacteria-free trachomatous material capable of 
inducing infections in monkeys. 
I believe that Thygeson is correct in assuming that the in-
fectious agent is of a virus nature on the basis of this 
evidence. In October, 1938 Thygeson and Richards (72) after 
a series of studies on the etiology of trachoma. came to the 
conclusions that the causative agent is filterable under cer-
tain conditions, that it has the characteristics ofa virus 
(filterability, inclusion body formation, non-cultivability 
on non-living media), that it is identical with the elemen-
tary body of Halberstadter and Prowazek. They also believe, 
in this paper, that the virus of trachoma., with the viruses 
of inclusion blenorrhea and psittacosis, form a group trans-
itional between Rickettsia and the typical viruses. 
In my opinion the balance of evidence presented thus 
far indicates that the infectious agent of trachoma is of 
a virus nature but the definite category has not been ade-
quately decided. In the next section the relation between 
the inclusion body and the virus nature will be pointed out 
and discussed because I believe that there is a definite 
relationship between the two. 
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Relationship of the Inclusion Body and the Virus Nature 
In 1934 Thygeson (64) reached the conclusion that the 
inclusion bodies of Halberstadter and Prowazek constitute 
intracellular colonies of the virus in various stages of 
development. He believed the small inclusions, made up of 
initial bodies, was the early phase of the virus while the 
large inclusion, ma.de up of elementary bodies, is the late 
phase. In 1935 Thygeson (71) in an experiment, using the 
colloidion membrane for filtration, confirmed the virus 
nature of the etiologic agent of trachoma., and offers evi-
dence to support the view that the trachoma virus and the 
trachoma. elementary body (Halberstadter and Prowazek) are 
identical. Again in 1938 Thygeson and Richards (72) state 
that they believe the elementary body of trachorra represents 
the morphologic unit of the virus of trachoma. because of 
the following findings:-
1- The identity in morphologic structure and staining re-
actions of the bodies of trachoma. with the similar bodies 
of inclusion blenorrhea and psittacosis, established 
virus diseases. 
2- The presence of the elementary bodies in an infective 
filtrate. 
3- The presence of the elementary body in the lesions of 
trachoma with sufficient constancy to indicate etiologic 
significance, 
2? 
4- Their multiplication in new hosts (man and baboons) 
when transferred directly or after filtration. 
5- Their persistance in the lesions of trachorna. through 
out the period of activity of the disease. 
In January, 1941 Julianelle (25) published a paper in which 
is suggested an actual relation of the inclusion body to 
infectivity to the extent that the inclusion represents an 
agglomeration of virus particles. However, he feels that 
this opinion requires further study before it can be fully 
accepted. 
In conclusion of this section I believe that the 
opinion stated by Julianelle substantiates the ideas of 
other observers but as is stated there will have to be 
further collaberation before anything definite can be 
decided. 
Conclusions 
In the final analysis of the question of the etiology 
of trachoma I am of the opinion that the major portion of 
evidence originating from different laboratories designates 
a virus as it's causative agent. Among the chief character-
istics indicative of viral activity is the cytoplasmic in-
clusion body identified with the epithelial cells of the 
conjunctiva and, occassionally even of the cornea. While 
opinion varies as to it's true significance, the majority 
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of observers, begining with Halberstadter and Prowazek, 
regard the inclusion body as actually the incitant itself 
or as a mass or colony of infectious units and more recently 
as agglomerations of virus particles. However, the evidence 
brought forward during all these years in support of these 
beliefs is essentially morphological, and as such it is 
subject to indiviuual interpretation. 
The successful treatment of trachoma, as shown in the 
next section, with sulfanilamide and the inability to cur-
tail various other virus diseases with the same drug might 
be considered by some as concrete evidence that trachoma is 
not of the virus class. But since modern research has not 
yet determined the definite nature of viruses, one might 
speculate that the agent of trachoma is a part of the life 
cycle of the virus which can be affected by chemotherapy, in 
this instance sulfanilamide, or that there are various species 
of viruses that will respond tb chemotherapeutic agents. 
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THE TP.EATMENT OF TRACHOMA WITH SUIJ'ANIL.AM:IDE 
Introduction 
Until very recently the management of trachoma has 
been largely a surgical problem. In the history of this 
very interesting disease there has been only one proced-
ure which has consistently persisted in spite of the var-
ious and numerous procedures advanced, The local appli-
cation of escharotic drugs, especially some form of copper, 
has been used for at least three thousand years. With the 
advent of chemotherapy approximately three years ago a 
revolution in the management of trachoma has occurred, 
chiefly because it is so easy to use, much less painful 
to the patient than the old procedures, and good results 
are secured by its use. 
In this section of my paper I propose to review the 
pertinent experimental work, which has been done during 
the last three years, in regard to the use of sulfanilamide 
and it's derivatives in the treatment of trachoma and sub-
sequently evaluate the publications that have been pub-
lished up to this time. 
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Review of Experimental Work 
The first report on the use of sulfanilamide com-
pounds in the treatment of trachoma was published in 
August, 1937 by Heinemann (19). Although his series con-
sisted of only three cases his results were so startling 
both to himself and the rest of the world that irmnediately 
other observers sought to determine the value of this 
miracle drug. And so we find that this was the begining 
of a problem which is not yet solved. 
In July, 1938 Lian (36) reported his observations on 
the results of the treatment of trachoma with sulfanilamide. 
His series consisted of thirty patients and he found that 
the conjunctival and corneal complications responded well. 
However, he comes to the conclusion the sulfanilamide is 
a valuable aid in combination with mechanical methods and 
alone will not cure the disease. 
In this country Dr. Fred Loe started to use sulfanil-
amide in trachoma at the same time Heinemann's report came 
out but he did not publish his work until October, 1938 (38). 
He states that in August, 193? he selected two patients, 
one of whom had trachoma for two years the other eighteen 
months, and treated them by giving one-third of a grain of 
sulfanilamide per pound of body weight each day along with 
an equivalent amount of sodium bicarbonate for the first 
ten days. Then for the next fourteen days he gave them 
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one-quarter of a grain of sulfanilamide per pound and an 
equal amount of sodium bicarbonate. Five days after the 
treatment was started he noticed that the redness of the 
conjunctiva was disappearing, the granules and papules 
were decreased in size and the blood vessels became in-
creasingly visible. As a result of his treatment he states 
that these two cases were apparently cured within one month. 
On January 6, 1938 he started treating thirteen patients 
sulfanilamide who had been under continuous treatment from 
one to seven years. Three of these patients were dismissed 
on Jan. 16, 1938 apparently cured, the other ten were greatly 
improved after eight days of treatment and were given sulf-
anilamide for two weeks longer. At the meeting of the 
American Medical Association in June, 1938 he reported the 
results of 140 cases of trachoma, as previously mentioned, 
and from the conclusions made it is assumed that all of the 
cases were arrested. 
In 1938, at the same time Loe presented his paper to 
the American Medical Association, Gradle (18) read a report 
on the treatment of a series of 41 patients with sulfanil-
amide in which 25 percent did not respond to treatment and 
75 percent, although not stated, are supposed to have been 
arrested. Even though his paper had been published before 
Loe's, Gradle gives all priority to him. 
Also in 1938 in Great Britian Kirk, McKelvie, and 
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Hussien (33) proceeded to try out sulfanilamide. They 
based their trial solely on some research work which had 
shown the value of the drug in healing a meningitis in-
duced in mice by the virus of Lymphogranuloma Inguinale 
and which showed Rickettsia-like bodies similar to those 
found in trachoma. They treated twenty-five patients using 
22t grains of sulfanilamide daily in alternate seven day 
courses. They noted that the greatest improvement was seen 
where pannus and keratitis were present. From their results 
they concluded that the permanent effectiveness of the 
drug still had to be ascertained. 
In a series of twenty-five patients, after two weeks 
of treatment and observation, Hirschfelder (23) got the 
impression that sulfanilamide has a paling and drying effect 
on the conjunctiva of trachoma stage II and milder cases 
of stage III. Also he noticed that it seemed to aid in the 
healing of pannus in cases that are not too old and not too 
malignant. He used the dosage and procedure recommended by 
Loe and reached the conclusion that the question whether 
or not the drug can completely arrest the disease or pre-
vent recurrences is still not settled. 
In April, 1939 Richards, Forster, and Thygeson (56) 
published a report of the treatment of twelve Indian child-
ren by the method of Loe. All of these children showed active 
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trachoma with follicular hypertrophy and pannus and all 
showed striking improvement. At the end of four and a 
half months the conjunctiva in each instance had become 
follicle free and smooth. In every eye, except one, there 
was a disappearance of corneal infiltrates and an apparent 
arrest of corneal activity. Also in every case the drug 
caused the disappearance of the epithelial cell inclusion 
so characteristic of active trachorna so it is assumed 
that all cases were arrested. 
In August, 1939 a very interesting paper appeared in 
the literature. Brav (4) treated one case of recurrent 
trachornatous ulceration of the cornea with instillation 
of a two and one-half percent solution of neoprontosil 
locally. This ulceration cleared up and the pain was re-
lieved by this procedure. This is the first instance of a 
sulfanilamide derivative being used locally. 
In October, 1939 at a staff meeting of the Mayo Clinic 
Harley, Brown, and Herrell (21) made known their findings 
of treating trachoma with sulfanilamide and it's derivatives. 
In a series of eleven cases, four of which were treated with 
neoprontosil because they were intolerant to sulfanilamide, 
they found marked objective and subjective improvement in 
each case. All cases were grouped as stage II or III accord-
ing to MacCallan's classification. In regard to neoprontosil 
they reached the conclusion that although the results were 
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not as dramatic they compare very favorably with those 
secured with sulfanilamide. 
The use of sulfapyridine in the treatment of trachoma 
was reported for the first time by Spearman and Vandevere 
(60) in November, 1939. Their series consisted of two cases 
that had been intractable to all other methods, one with 
sulfanilamide. They were greatly impressed with the remark-
able remission of pathologic signs and the improvement of 
vision secured. 
In November, 1939 Julianelle, Lane, and Whitted (29) 
published their results on a series of 113 patients, all 
were Indians except for six white patients. They used the 
dosage recommened by Loe and found that twenty percent re-
covered, forty percent showed varying degrees of improve-
ment and forty percent were not improved. So they reached 
the conclusion that the drug has marked and rapid effect 
on the secondary infections commonly associated with trachoma 
and that most striking results were seen in those patients 
with exacerbative disease. 
Wilson (?6) reported a series of eighteen patients 
that recieved one-third grain of sulfanilamide per pound 
of body weight each day for three weeks and then one-quarter 
of a grain per pound each day for three weeks. He also used 
a two percent ointment locally and secured an arrest of the 
disease process in all cases. 
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Lugossy (39) in a report published December, 1939 
found that sulfanilamide preparations were of the greatest 
value in those cases of trachoma. which were complicated by 
pannus and corneal ulcers. However, he concludes that sulf-
anilamide itself does not cure trachoma but hastens the 
curative effects of such remedies as injection of foreign 
proteins. 
Another large series consisting of 100 patients was 
reported by Sie-Boen~Lian in December, 1939 (37). He re-
ached the conclusions that the drug was effective in re-
ducing secretion and diffuse thickening, papillary thick-
ening influenced but little, the granules were not affected, 
and that the corneal complications (pannus, keratitis, 
corneal ulcer) responded best of all. He also found that 
recurrences of complications were rare. 
In March, 1940 Spining (61) in Ganado, Arizona being 
stimulated by Loe's report and using the dosage outlined by 
him reports the treatment of fifteen adults with chronic 
trachoma associated with other acute eye conditions, such 
as bulbar conjunctivitis, phylycentular conjunctivitis, and 
corneal ulcers. He found that all of them recovered rapidly 
from the acute manifestations but in none of them could he 
find any evidence that the underlying trachoma. was cured or 
even greatly improved. He also reports that seventeen child-
ren between the ages of eight and fourteen years with chronic 
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trachoma. and little or no bulbar or corneal involvement 
other than slight pannus were treated with sulfanilamide 
for periods of seven to twenty-four days. In only one of 
these children was a clinical cure obtained, the other 
sixteen showed only slight to moderate improvement. 
MacCallan (41) of the British school in March, 1940 
published a report after using sulfapyridine. The report 
does not say how many cases were treated but the dosage 
used was three grams the first day and two grams on each 
succeeding day for nine days along with an equivalent 
amount of sodium bicarbonate. He concludes that up to the 
present time the drugs of the sulfonamide group have been 
found to be without effect on any virus disease and con-
sequently has no effect on trachoma., since it is of the 
virus class. He believes that the good results obtained 
in the treatment of trachoma. by these drugs have been pro-
cured by the elimination of superimposed bacterial in-
fections. 
The results secured in another large series was re-
ported in :May, 1940 by Forster ( 14). He used sulfanilamide 
in a dosage of one-half grain per pound of body weight daily, 
divided into four doses, for twenty-one days then if there 
was any evidence of trachoma.tous activity they were given 
a second course identical with the first. The disease, in 
125 out of 167 trachoma.tous children became clinically 
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arrested following the one course. In the rest, the dis-
ease became arrested following the second course. He found 
that the effect of the drug on stage I was very striking, 
the conjunctiva and cornea returning to normal in ten days, 
but in the advanced cases the effect was slower. 
Also in May, 1940 Kettler and Rutherford (32) reported 
a series of 63 patients out of which eight eyes were blind, 
one globe shrunken, and one enucleated. They used ten grains 
of sulfanilamide three times daily the first week and then 
ten grains twice a day for four to eight weeks and instilled 
into the conjunctival sac one drop of a two and half percent 
solution of neoprontosil four times daily. If the eyelid 
deformities were bad the patient was hospitalized and surgi-
cal correction done and during the time of hospitalization 
one-third grain per pound, maximum of forty grains, was given 
orally. They found that out of the 116 eyes capable of being 
improved the vision in 56 of them was improved. They con-
cluded that improvement occurred in inverse proportion to 
the number and severity of complications, that the acute 
exacerbations of old trachoma with infective secretion are 
quickly controlled, that you can cure practically all in 
whom the infection has been recently acquired and where no 
complications have developed. 
Thygeson (69) in June, 1940 reported a series of 31 
cases of trachoma treated with sulfanilamide. Of these 16 
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were healed, 11 showed satisfactory improvement, and 4 
exhibited little or no change. He concludes that his re-
sults confirm the claims of Loe and others that sulfanil-
amide exerts a definite curative effect in a high percent-
age of active trachoma cases. He also states that the effect 
is primarily on the trachoma virus rather than on the sec-
ondary invaders because of the striking results obtained 
in pure, uncomplicated cases and by the uniform disappear-
ance of the epithelial cell inclusion bodies characteristic 
of the active disease. 
As a result of work done by them in China, Lee and 
Rottenstein (34) reported a series of 95 cases in July, 1940. 
Seventy-five of these patients were treated by giving a 
daily dose of sulfanilamide of 0.02 gm. per pound of body 
weight for two to four weeks. Twenty of these patients were 
treated with sulfanilamide given intramuscularly in a dose 
of two to five grams per injection. Sulfanilamide was given 
every four days and sulfapyridine every seven to ten days, 
with a total of two to six injections being all that was 
necessary. They concluded that the treatment was effective 
in stages I,II, and III and that the intramuscular route 
was most effective. 
In August, 1940 Hammond (20) reported a series of 12 
cases of acute trachoma. that were treated by giving sulf-
anilamide in doses of forty grains per day for two weeks, 
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thirty grains for three weeks, and twenty grains for two 
to six months, depending on how often the patients returned 
to have their prescriptions filled. He found that in every 
case there was marked improvement or complete arrest. 
Also in August, 1940 Cosgrove (8) reported a series of 
107 cases treated with both oral and local sulfanilamide. 
He reports that equal improvement of visual acuity was ob-
tained by both methods individually and that the sympto-
matic relief of the patient with trachoma on local aulf-
anilamide is apparently as rapid and complete as that ob-
tained from oral use. He also suggests that it may be possible 
to prevent the recurrence of trachoma. after sulfanilamide 
therapy by the continued local use of the drug. 
In September, 1940 Cooper (?) reported some observations 
which are entirely different from others and very interesting. 
In a series of 34 patients with trachoma. treated with sulf-
anilamide, a recurrence of 62 percent was encountered with-
in six to thirty months. Of those recurrences 16 were treated 
subsequently with iontophoresis and none had a second re-
currence, a majority of them being followed for over two 
years. He suggests that routine treatment of trachoma consist 
of at least eight applications of quinine bisulphate by 
iontophoresis following apparent cure by sulfanilamide, as 
a prophylactic measure against recurrence. However, he warns 
that you cannot carry out iontophoresis until aulfanilamide 
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therapy has been completed because of the danger of pro-
ducing a harsh reaction in the ocular tissues. 
The latest report available was published in Feb., 
1941 by Smith, Julianelle, and Gamet (59). In their series 
of 26 patients they used the dosage recommended by Loe. 
Their results show that two cases were arrested, 11 were 
improved but still clinically active, and 13 remained in 
a stationary clinical condition. In the final analysis 
they admit that 50 percent of the patients treated profited 
from the administration of sulfanilamide. 
Summary of Reports Reviewed 
Twenty-four reports on the observations of various 
observers have been reviewed. Of these all but those of 
Heinemann (19), Brav (4), Spearman and Vandevere (60), 
and Lugossy (39) can be fairly judged as to the results 
of treatment of trachoma by sulfanilamide and it's de-
rivatives. 
Although all observers agree that trachomatous 
patients secure relief of objective and subjective symp-
toms, not all of them agree that the disease process is 
arrested. Julianelle, Lane, and Whitted (29), Spining (61), 
Cooper (7), Smith, Julianelle, and Gamet (59) had com-
paratively poor results but even at that I believe they had 
a fair enough percentage of arrestment of the disease 
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process to warrant the use of sulfanilamide in the future. 
Julianelle, Lane, and Whitted (29) and MacCallan (41) using 
sulfapyridine, believed that the good results they did 
secure was due to the effect on secondary invaders and 
MacCallan states it has no effect on trachoma. 
All the observers not mentioned in the preceeding 
section had very good results, especially when the disease 
was of recent origin but in numerous instances long standing 
cases were cleared and arrested. Thygeson (69), in direct 
opposition to M:acCallan (41), states that the drug has a 
direct effect on the virus and little effect on the secon-
dary invaders. 
Several observers have recommended that some other form 
of treatment be used in conjunction with sulfanilamide 
therapy, or that sulfanilamide or neoprontosil be used 
locally alone or in conjunction with oral use of sulfanil-
amide. I,ian (37) believes that some form of mechanical 
treatment should be used with sulfanilamide therapy; Brav (4) 
secured excellent results in one case from local use of 
neoprontosil; Wilson (76) using sulfanilamide locally and 
and orally secured excellent results; Kettler and Ruther-
ford (32) using neoprontosil locally with oral use of 
sulfanilamide had excellent results; Cosgrove (8) secured 
favorable results from the use of sulfanilamide both orally 
and locally; Cooper (7) by using iontophoresis in the 
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recurrent cases of trachoma following sulfanilamide 
therary had excellent results. 
It seems that dosage and treatment time are probably 
the two most important factors in explaining the varying 
response of trachoma to sulfanilam.ide. The importance of 
adequate dosage is well shown in the two series reported 
by Richards, Forster, and Thygeson (56) and by Forster (14) 
in which almost uniform healing was obtained on a daily 
dosage of one-half grain of sulfanilam.ide per pound of 
body weight continued for three weeks or longer, however, 
the toxic effects of the drug, especially in regard to the 
hemopoetic system, must always be kept in mind. 
Conclusions 
The experience of innumerable observers in the treatment 
of trachoma with various methods during the entire history of 
the disease definitely shows that it is impossible to attain 
complete recovery in all patients and complete lack of re-
currence in all individuals. So in the final analysis I be-
lieve that sulfanilamide has made a most prominent place for 
itself in the treatment of trachoma and that it will stand the 
test of time much better than previous forms of treatment ex-
cept possibly the use of escharotic agents. Also the few 
reports that are available on the subject, indicate that the 
use of sulfanilamide or one of it's derivatives locally in 
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conjunction with oral therapy of sulfanilamide or some 
other local treatment such as that suggested by Cooper 
(7) may be bf definite value but the literature is not 
sufficient enough to judge fairly. 
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